Dominick Bossé

3.9k total citations · 1 hit paper
71 papers, 1.5k citations indexed

About

Dominick Bossé is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Dominick Bossé has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Dominick Bossé's work include Renal cell carcinoma treatment (26 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dominick Bossé is often cited by papers focused on Renal cell carcinoma treatment (26 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dominick Bossé collaborates with scholars based in Canada, United States and Spain. Dominick Bossé's co-authors include Toni K. Choueiri, Joaquim Bellmunt, Aly‐Khan A. Lalani, Guillermo de Velasco, Patrick A. Ott, Raphael Brandão Moreira, Lauren C. Harshman, F. Stephen Hodi, Rana R. McKay and Fabio A.B. Schutz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dominick Bossé

66 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

2017 369 citations Guillermo de Velasco, Youjin Je et al. Cancer Immunology Research profile →

Peers

Countries citing papers authored by Dominick Bossé

Since Specialization

Citations

This map shows the geographic impact of Dominick Bossé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominick Bossé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominick Bossé more than expected).

Fields of papers citing papers by Dominick Bossé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominick Bossé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominick Bossé. The network helps show where Dominick Bossé may publish in the future.

Co-authorship network of co-authors of Dominick Bossé

This figure shows the co-authorship network connecting the top 25 collaborators of Dominick Bossé. A scholar is included among the top collaborators of Dominick Bossé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominick Bossé. Dominick Bossé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma 2025 ·The Oncologist ·(unknown), Zineb Hamilou, Sunita Ghosh, Daniel Yick Chin Heng, Lori Wood, Naveen S. Basappa, Christian Kollmannsberger, Jeffrey Graham, Bimal Bhindi, Antonio Finelli, Georg A. Bjarnason, Dominick Bossé, Frédéric Pouliot, Vincent Castonguay, Rodney H. Breau, Ramy Saleh, Eric Winquist, Aly‐Khan A. Lalani, Denis Soulières	1
2	Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis) 2024 ·Clinical Genitourinary Cancer ·Jeffrey Graham, Sunita Ghosh, Rodney H. Breau, Lori Wood, Simon Tanguay, Dominick Bossé, Aly‐Khan A. Lalani, Bimal Bhindi, Daniel Yick Chin Heng, Antonio Finelli, Nazanin Fallah‐Rad, Vincent Castonguay, Naveen S. Basappa, Denis Soulières, Frédéric Pouliot, Christian Kollmannsberger, Georg A. Bjarnason	0
3	565P Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: The phase II NEO trial (CCTG CO.28) results after minimum 3 years follow up 2024 ·Annals of Oncology ·Carl J. Brown, C. O'Callaghan, Jonathan M. Loree, (unknown), Roland N. Auer, (unknown), Manan Raval, X. Grace, Antonio Caycedo‐Marulanda, Vlad V. Simianu, Sunil V. Patel, (unknown), Ramzi M. Helewa, Vallerie Gordon, (unknown), Dominick Bossé, Marianne Krahn, (unknown), (unknown)	0
4	Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database 2024 ·Current Oncology ·(unknown), (unknown), Sunita Ghosh, Lori Wood, Georg A. Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frédéric Pouliot, Christian Kollmannsberger, Dominick Bossé, Naveen S. Basappa, Antonio Finelli, Nazanin Fallah‐Rad, Rodney H. Breau, Aly‐Khan A. Lalani, Simon Tanguay, Jeffrey Graham, Ramy Saleh	3
5	Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System 2023 ·JCO Global Oncology ·(unknown), Sunita Ghosh, Antonio Finelli, Lori Wood, Christian Kollmannsberger, Naveen S. Basappa, Jeffrey Graham, Daniel Y.C. Heng, Georg A. Bjarnason, Denis Soulières, Dominick Bossé, Vincent Castonguay, Ramy Saleh, Simon Tanguay, Bimal Bhindi, Rodney H. Breau, Frédéric Pouliot, Aly‐Khan A. Lalani	1
6	What Attributes Matter Most in Physicians? Exploratory Findings from a Single-Centre Survey of Stakeholder Priorities in Cancer Care at a Canadian Academic Cancer Centre 2023 ·Current Oncology ·(unknown), (unknown), (unknown), Dominick Bossé, Paul Wheatley‐Price	1
7	Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer 2022 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Kristen McAlpine, (unknown), Marc Carrier, Dominick Bossé, (unknown), Ranjeeta Mallick, Ilias Cagiannos, Christopher Morash, Rodney H. Breau, Luke T. Lavallée	4
8	Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews 2022 ·Drugs ·Salmaan Kanji, (unknown), (unknown), (unknown), (unknown), Dominick Bossé, Xiang Wang, Carole Lunny, Brian Hutton	9
9	Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence 2020 ·Annals of Surgical Oncology ·(unknown), (unknown), Dominick Bossé, (unknown), Xinni Song, Carolyn Nessim, Michael Ong	12
10	Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer 2020 ·Cancer Chemotherapy and Pharmacology ·Igal Kushnir, Ranjeeta Mallick, Michael Ong, Christina Canil, Dominick Bossé, (unknown), Neil Reaume	4
11	Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor–Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases 2018 ·Clinical Cancer Research ·Rana R. McKay, Dominick Bossé, Kathryn P. Gray, M. Dror Michaelson, Katherine M. Krajewski, Heather A. Jacene, Meghara Walsh, Joaquim Bellmunt, Mark M. Pomerantz, Lauren C. Harshman, Toni K. Choueiri	26
12	Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma 2018 ·Journal for ImmunoTherapy of Cancer ·Aly‐Khan A. Lalani, Wanling Xie, Dylan J. Martini, John A. Steinharter, Craig Norton, Katherine M. Krajewski, (unknown), Dominick Bossé, Joaquim Bellmunt, Eliezer M. Van Allen, Bradley A. McGregor, Chad J. Creighton, Lauren C. Harshman, Toni K. Choueiri	197
13	Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients breakdown → 2017 ·Cancer Immunology Research ·Guillermo de Velasco, Youjin Je, Dominick Bossé, Mark M. Awad, Patrick A. Ott, Raphael Brandão Moreira, Fabio A.B. Schutz, Joaquim Bellmunt, Guru Sonpavde, F. Stephen Hodi, Toni K. Choueiri	369
14	Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis 2017 ·Clinical Genitourinary Cancer ·Elena Sevillano, Lillian Werner, Dominick Bossé, Aly‐Khan A. Lalani, Stephanie A. Wankowicz, Guillermo de Velasco, (unknown), (unknown), Toni K. Choueiri, Aranzazu González del Alba, Joaquim Bellmunt	4
15	Pan-urologic cancer genomic subtypes that transcend tissue of origin 2017 ·Nature Communications ·Fengju Chen, Yiqun Zhang, Dominick Bossé, Aly‐Khan A. Lalani, A. Ari Hakimi, James J. Hsieh, Toni K. Choueiri, Don L. Gibbons, Michael Ittmann, Chad J. Creighton	48
16	Pazopanib (p) or sorafenib (s) + radium-223 (rad) in metastatic renal cell carcinoma (mrcc) with bone metastases (bm) 2017 ·Annals of Oncology ·Dominick Bossé, (unknown), Kathryn P. Gray, M. Dror Michaelson, (unknown), Meghara Walsh, Katherine M. Krajewski, Heather A. Jacene, Joaquim Bellmunt, Mark M. Pomerantz, Lauren C. Harshman, Toni K. Choueiri	2
17	Tumour Lysis Syndrome in Solid Tumours Associated with Tyrosine Kinase Inhibitors – A Case Illustrated Review 2016 ·European Oncology & Haematology ·Dominick Bossé, Esmeralda Celia Marginean, D. Blair Macdonald, Garth Nicholas, Shailendra Verma	0
18	PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium 2016 ·Clinical Colorectal Cancer ·Dominick Bossé, (unknown), Soundouss Raissouni, Kristopher Dennis, Rachel Goodwin, Di Jiang, Erin Powell, Aalok Kumar, Richard M. Lee‐Ying, (unknown), Daniel Y.C. Heng, Patricia A. Tang, Anthony R. MacLean, Winson Y. Cheung, Michael M. Vickers	21
19	Total liquid ventilation efficacy in an ovine model of severe meconium aspiration syndrome 2011 ·Critical Care Medicine ·(unknown), Dominick Bossé, (unknown), (unknown), Roula Albadine, Jean‐Paul Praud, Raymond Robert, Philippe Micheau, Hervé Walti	19
20	Experimental Validation of Cardiac Index Measurement Using Transpulmonary Thermodilution Technique in Neonatal Total Liquid Ventilation 2010 ·ASAIO Journal ·Dominick Bossé, Hervé Walti, Raymond Robert, (unknown), Olivier Lesur, Jean‐Paul Praud, Philippe Micheau	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact